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Abstract
Purpose: To present a single-centre experience with endovascular treatment of patients with severe symptoms sec-
ondary to acute pulmonary embolism (PE). 
Material and methods: Twenty-five patients were treated due to contraindications or deficient effects of systemic throm-
bolytic therapy. The patients were treated with a combination of fragmentation and aspiration, only aspiration, or 
only fragmentation, and with catheter-directed thrombolytic therapy.
Results: The saturation was improved following treatment in all patients, except in one where the procedure could 
not be completed. There were no immediate or late procedure-related complications.
Conclusions: Endovascular treatment of severe PE is a safe and efficient option in patients with failing effect or contra-
indication to systemic thrombolysis. 
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Introduction 
Acute pulmonary embolism (PE) is a severe condition 
with a high risk of mortality. The severity of symptoms 
may vary, but most often include dyspnoea, chest pain, 
cough, and in some cases haemoptysis. Unstable patients 
are presented with a drop in blood pressure (BP) and tach-
ycardia, and untreated they may progress to circulatory 
collapse [1]. Following clinical examination and labora-
tory tests the diagnosis is commonly verified by echocar-
diography (ECO) and/or computer tomography (CT). 
A pulmonary angiography (PAI) and pulmonary venti-
lation/perfusion scan may be performed in specialised 
hospitals [2-4]. 
Haemodynamically unstable patients are traditionally 
treated with systemic thrombolysis or open embolecto-
my [5]. However, there are several contraindications for 
thrombolysis, for instance current or threatening bleed-
ing, stroke, recent surgery or delivery, trauma, or malig-
nant diseases. 
For patients with contraindications or insufficient 
effect of systemic thrombolysis, endovascular treatment 
may be an option [5-11]. Endovascular methods include 
catheter-directed administration of thrombolytics (CDT), 
fragmentation and/or aspiration of emboli, or a combina-
tion of these methods. An inferior vena cava (IVC) filter 
is often placed to prevent further embolisation [12-19].
We retrospectively present our results of the endovas-
cular treatment in 25 patients with acute, severe PE.
Material and methods
Of the 25 patients, 17 were male and eight female, age 
range 31-83 years. The treatment was performed due to 
contraindications including gastro-intestinal (G-I) bleed-
ing (n = 2), malignancy (n = 4), stroke (n = 3), recent 
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surgery (n = 3), risk of bleeding (n = 3), recent cardio-pul-
monary resuscitation (n = 1), migrating thrombus, and in-
sufficient effect of systemic thrombolysis (n = 8) (Table 1).
Ten patients presented at the emergency department 
with dyspnoea and five with chest pain/cardiac arrest. The 
remaining patients were hospitalised at the time of acute 
PE due to malignancy, stroke, or palliation. Five patients 
were haemodynamically unstable with SBP<90 at the time 
of the procedure. The saturation was moderate or severely 
decreased in all patients, measuring between 69 and 97% 
(mean 86%) with oxygen support. The respiratory frequency 
was measured in 19 patients, with a mean value of 23/min.
Echocardiography (ECO) was performed in 20 pa-
tients, and 19 or them had signs of right heart strain. 
The extent of the PE was verified by CT scans in all pa-
tients. The Miller Index was used to quantify pulmonary 
arterial obstruction, with a mean value of 14.6 (patient 
number = 11, 12, 13, 14, 15, 20).
All procedures except one were performed with local 
anaesthesia, with continuous monitoring of BP, heart rate, 
and saturation. Following puncture of the right common 
femoral vein, an IVC filter (Celect, Cook Sweden AB, 
Askim, Sweden) was positioned in the infrarenal IVC if 
indicated, to prevent further embolisation. Thereafter, 
a 70 cm long 9 F introducer was placed with the tip in the 
IVC close to the right atrium. The tip of a 7 F APC catheter 
(Cook Sweden AB) was thereafter advanced through the 
introducer to the left and right main pulmonary arteries 
and diagnostic angiograms were performed. Subsequently 
the introducer tip was advanced over a Glidewire (Terumo 
Sweden AB, Västra Frölunda, Sweden) to the main pulmo-
nary trunk. In cases with occlusive central emboli frag-
mentation attempt was done using rotation of the tip of 
a 5 F pigtail catheter (Cordis, Sollentuna, Sweden) placed 
over the guidewire in the left and/or right pulmonary ar-
tery. Following exchange of the guidewire to a 0.018 wire 
Table 1. Patients and treatments
Patient
no
Age Gender History/Actual problem Indication for endovascular treatment IVC filter Endovascular 
treatment
1 58 M Pulmonary transplant Recent surgery Yes CDT
2 64 M Liver malignancy Recent surgery Yes A
3 69 M Chest pain + cardiac arrest Insufficient effect of systemic thrombolysis No F + A
4 70 M Intracranial haemorrhage Stroke Yes F + A
5 70 F Chest pain Risk of bleeding (aorta aneurysm) Yes F + A
6 79 M Pneumonia + sepsis Insufficient effect of systemic thrombolysis No F
7 42 M Urachus malignancy Malignancy Yes A
8 58 F Leiomyosarcoma Malignancy No F + A + CDT
9 72 M Dyspnoea Migrating thrombus No F + A
10 68 F Dyspnoea GI-bleeding Yes F
11 68 F Cardiac arrest Recent CPR Yes F + A
12 66 M Cerebral malignancy GI-bleeding Yes F + A
13 78 M Dyspnoea Insufficient effect of systemic thrombolysis No F + A
14 63 F Stroke + cardiac arrest Stroke Yes F + A
15 82 M Dyspnoea Insufficient effect of systemic thrombolysis No F + CDT
16 71 M Dyspnoea Insufficient effect of systemic thrombolysis Yes F + A
17 61 M Pancreatic malignancy Malignancy No F
18 64 M Intracranial haemorrhage Stroke Yes A
19 69 M Pneumonia + deep vein thrombosis Risk of bleeding (infection) Yes F + A
20 57 M Chest pain + dyspnoea Risk of bleeding (after coronary a i) Yes F
21 69 F Dyspnoea Malignancy Yes F + A
22 43 F Dyspnoea Insufficient effect of systemic thrombolysis Yes A
23 74 M Intracranial surgery Recent surgery Yes F + A
24 31 F Recent delivery Insufficient effect of systemic thrombolysis No F + A
25 63 M Dyspnoea + cardiac arrest Insufficient effect of systemic thrombolysis Yes F + A
A – aspiration, CDT – catheter-directed therapy, CPR – cardio pulmonary resuscitation, F – fragmentation
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(Boston Scientific, Helsingborg, Sweden), an Arrow- 
Trerotola positioned over the wire percutaneous thrombo-
lytic device (PTD – Arrow Int. Inc., Reading PA, USA) [20] 
was advanced into the pulmonary trunk, and fragmenta-
tion of the emboli in the main and segmental branches 
was performed. Aspiration of emboli was done using 
an 8 F JR4 guiding catheter (Cordis). In three patients 
CDT was administrated though a 4 F Cobra C2 catheter 
(Cordis) or a 4 F MPA catheter (Terumo) placed with the 
tip in the embolus in the main right or left pulmonary ar-
tery, using alteplase (Actilyse, Boerhinger Ingelheim AB, 
Stockholm, Sweden). The results of all the treatments were 
verified during the procedure by multiple contrast injec-
tions and by final angiography (Figure 1A-C). 
Results
One patient in severe, unstable condition and with ex-
tensive PE expired during the attempted fragmentation 
due to circulatory arrest that could not be reversed. 
The procedures were successfully completed in the other 
24 patients. In 17 patients an IVC filter was placed during 
the procedure. In 14 of the 23 patients fragmentation and 
aspiration of the emboli were performed. In four patients 
aspiration only and in another four fragmentation only 
was performed. CDT alone was performed in one patient, 
in whom mechanical or systemic treatment was contrain-
dicated due to recent surgery (patient 1). In two other 
patients, CDT was combined with mechanical removal 
(patient 8 and 15) due to large emboli burden. 
The final angiography showed improved flow in the 
pulmonary circulation in all patients. One of these patients 
was, however, subsequently treated by surgical embolecto-
my due to recurrent circulatory instability. The treatment 
had good primary effect with immediate improvement of 
saturation in all the other patients, and there were no pro-
cedure-related complications (Table 1). 
The mean time of hospitalisation after the procedure 
was 12.5 days, including less than half a day of observa-
tion in the intensive care unit. 
Figure 1. A) Emboli in the right pulmonary artery causing perfusion defects. 
B) Arrow-Trerotola in place in the artery to the lower lobe. C) Result after 
the endovascular treatment with improvement of the perfusion
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During follow-up (up to 42 months) nine patients ex-
pired. One died due to pneumonitis after three days, and 
one due to anoxia of the brain following heart arrest (re-
versed prior to the procedure) after 12 days. One patient 
expired due to aortic dissection more than one year after 
treatment, two due to unknown causes after more than six 
months, and the others later due to underlying disorders.
Discussion 
Acute PE is a severe condition with substantial morbid-
ity and mortality (15-18%) within the first three months 
[21]. Late complications such as chronic thromboembolic 
pulmonary hypertension may cause significant morbid-
ity [22]. The traditional treatment includes anticoagu-
lant therapy in haemodynamically stable patients, while 
unstable patients are treated with systemic thrombolysis 
or open surgery. Open surgery is an extensive procedure 
that carries substantial risk of complications [12]. System-
ic thrombolysis usually has good effect but contains risks 
and contraindications, such as ongoing or expected bleed-
ing, recent stroke, trauma, surgery or delivery, known gas-
trointestinal ulceration, and some malignant diseases. 
Endovascular treatment of patients with massive PE 
was reported previously [6-12]. There are several strate-
gies of endovascular treatment. A widely used therapy is 
CDT, where the thrombolytic agent is administrated di-
rectly into the embolus, with a potent local effect [12,13]. 
A percutaneous central PE fragmentation may be done us-
ing rotation of, for example, a pigtail catheter. The smaller 
fragments migrate more peripherally, increasing total pul-
monary perfusion and relieving right ventricular afterload, 
and may augment the effect of the thrombolysis [12,14]. 
Several different aspiration devices are available, some 
with combined fragmentation with drug infusion-function 
[13,15]. Ultrasound-assisted catheter-directed thromboly-
sis is another relatively new method, but one that requires 
treatment lasting about 20 hours [16-19]. We retrospec-
tively report our experience of interventional treatment of 
patients with severe symptoms secondary to massive PE, 
in which conventional treatment failed or could not be 
performed.
All our patients were severely symptomatic, and system-
ic thrombolysis was contraindicated or unsuccessful in all of 
them. Due to the urgency of the procedures registration of 
the different parameters such as pulmonary artery pressure 
was not performed. The procedures had, however, a prima-
ry prompt effect with substantial improvement of satura-
tion, which persisted during the patients’ hospital stay.
Mechanical fragmentation of the PE using intravas-
cular methods and devices was previously described [12]. 
The Arrow-Trerotola PTD is relatively common in the 
treatment of thrombosed dialysis grafts [20] but may also 
be used in native fistulas [23] and in peripheral veins [24]. 
However, to our knowledge use of this device in the treat-
ment of PE was not previously reported. For aspiration of 
the embolic material we used cardiac guiding catheters 
due to their large inner lumen and good torque ability, 
allowing easy positioning in more peripheral branches. 
There were no procedure-related complications. Most 
of our patients had PE secondary to severe underlying dis-
eases, which was the main cause of the prolonged hospital 
stay after intervention. The causes of deaths were not re-
lated to the procedures. 
We conclude that the treatment of the acute PE using 
our methods is safe and efficient in the majority of patients 
and may be recommended. 
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Figure 2. Aspirated emboli
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